Sferruzza, G.
Clarelli, F.
Mascia, E.
Ferrè, L.
Ottoboni, L.
Sorosina, M.
Santoro, S.
Moiola, L.
Martinelli, V.
Comi, G.
Martinelli Boneschi, F.
Filippi, M.
Provero, P.
Esposito, Federica http://orcid.org/0000-0003-2550-0805
Funding for this research was provided by:
Fondazione Italiana Sclerosi Multipla (FISM2013/R/13)
Article History
Received: 11 February 2021
Accepted: 20 June 2021
First Online: 28 June 2021
Declarations
:
: The local independent Ethical Committee approved the study protocol and all patients signed the informed consent before enrolling in the study.
: Not applicable.
: G. Sferruzza, F. Clarelli, E. Mascia, L. Ferrè, L. Ottoboni, M. Sorosina, S. Santoro, P. Provero report no competing financial interest.L. Moiola received honoraria for speaking or partecipating to advisory board from TEVA, Novartis, Biogen, Sanofi e Roche.V. Martinelli has received honoraria for consulting services or speaking activity from Biogen, Merck, Novartis, TEVA, Almirall, and Genzyme.G. Comi has received G. Comi has received personal compensation for consulting and speaking activities from Novartis, Teva, Sanofi Genzyme, Merck, Biogen, Roche, Almirall, Celgene, Forward Pharma, Medday and Excemed.F. Martinelli Boneschi has received compensation for activities with Teva Neuroscience, Biogen Idec, Merck Serono as speaker and/or advisor.M Filippi is Editor-in-Chief of the Journal of Neurology; received compensation for consulting services and/or speaking activities from Biogen Idec, Merck-Serono, Novartis, Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck-Serono, Novartis, Teva Pharmaceutical Industries, Roche, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA).F. Esposito received honoraria from Novartis and received research support from the Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla and European Union (Horizon 2020 Research and Innovation programme).